2m 2m 2m 2m 2m 2m 2m
Radnostix (INIS)
OTC
$0.07-$0.008 (-9.77%)
Price as of Jun 03, 2026- $26.5MMarket Cap
- 4.56%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Radnostix (INIS)
$0.07-$0.008 (-9.77%)
INIS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.07 | ||
Change | -$0.008 (-9.77%) | ||
Open | $0.07 | ||
High | $0.07 | ||
Low | $0.07 | ||
Previous Close | $0.08 | ||
Volume | 1,827 | ||
30-Day Average Volume | 49,268 | ||
1-Week Change | -8.85% | ||
1-Month Change | -7.85% | ||
1-Year Change | 4.56% | ||
3-Year Change | 4.56% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 519.8M | ||
Total Assets | $16.2M | ||
Market Cap | $26.5M | ||
Enterprise Value | $25.7M | ||
Period: QTR TTM FY | |||
Revenue | $2.9M | ||
Net Income | -$348,605.00 | ||
Free Cash Flow | -$786,910.00 | ||
EBIT | -$266,259.00 | ||
EBITDA | -$179,628.00 | ||
Net Working Capital | $1.9M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -143 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 6 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -34 | ||
Price/Operating Cash Flow | -88 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||